Pharma BD Deal Intelligence
Pfizer Inc. / Anacor Pharmaceuticals
2016 · Acquisition/Merger · $5.2B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
43
Underwhelmed — fell short of the thesis.
Pfizer acquired Anacor Pharmaceuticals for $5.2B for inflammation and immunology drugs.
Key facts
- Announced May 16, 2016
- Closed Jun 24, 2016
- Deal value $5.2B
- Deal type Acquisition/Merger
- Therapeutic area Dermatology, Immunology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals